Harvard Bioscience (HBIO) Tax Provisions (2010 - 2026)
Harvard Bioscience (HBIO) reported Tax Provisions of $117000.0 for Q1 2026, up 123.4% year-over-year from $52372.4 in Q1 2025, and down 40.31% quarter-over-quarter from $196000.0 in Q4 2025.
Harvard Bioscience (HBIO) Tax Provisions (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Tax Provisions data on file, last reported at $117000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $117000.0, up 123.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $438000.0 (up 2676.47% YoY), and the FY2025 annual result was -$133000.0, down 117.97% from the prior year.
- Tax Provisions eased to $117000.0 in Q1 2026 per HBIO's latest filing, from $196000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $1.3 million in Q4 2022 and troughed at -$1.3 million in Q3 2022.
- A 5-year average of $125529.4 and a median of $196000.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions sank 704.65% in 2022, then jumped 685.0% in 2023.
- A 5-year view of Tax Provisions shows it stood at $1.3 million in 2022, then sank by 61.71% to $487000.0 in 2023, then grew by 17.45% to $572000.0 in 2024, then sank by 65.73% to $196000.0 in 2025, then sank by 40.31% to $117000.0 in 2026.
- Business Quant data shows HBIO's Tax Provisions at $117000.0 in Q1 2026, $196000.0 in Q4 2025, and $97000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 114.40 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 76.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 52.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.58 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 29.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 36.12 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 11.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 117,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | 572,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -400,000.00 |
| Mar 31, 2024 | 210,000.00 |
| Dec 31, 2023 | 487,000.00 |
| Sep 30, 2023 | 677,000.00 |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | 585,000.00 |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | -1.30 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 541,000.00 |
| Sep 30, 2021 | 215,000.00 |
| Jun 30, 2021 | -200,000.00 |